Medistim ASA
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardiac and vascular surgery in the United States, Asia, Europe, and internationally. The company offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and TTFM in… Read more
Medistim ASA (MEDI) - Total Assets
Latest total assets as of June 2025: Nkr535.04 Million NOK
Based on the latest financial reports, Medistim ASA (MEDI) holds total assets worth Nkr535.04 Million NOK as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Medistim ASA - Total Assets Trend (2004–2024)
This chart illustrates how Medistim ASA’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Medistim ASA - Asset Composition Analysis
Current Asset Composition (December 2024)
Medistim ASA's total assets of Nkr535.04 Million consist of 74.6% current assets and 25.4% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr0.00 | 31.2% |
| Accounts Receivable | Nkr68.98 Million | 12.0% |
| Inventory | Nkr160.52 Million | 27.9% |
| Property, Plant & Equipment | Nkr73.16 Million | 12.7% |
| Intangible Assets | Nkr55.61 Million | 9.7% |
| Goodwill | Nkr14.13 Million | 2.5% |
Asset Composition Trend (2004–2024)
This chart illustrates how Medistim ASA's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Medistim ASA's current assets represent 74.6% of total assets in 2024, a decrease from 79.8% in 2004.
- Cash Position: Cash and equivalents constituted 31.2% of total assets in 2024, down from 36.3% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, unchanged from 11.0% in 2004.
- Asset Diversification: The largest asset category is inventory at 27.9% of total assets.
Medistim ASA Competitors by Total Assets
Key competitors of Medistim ASA based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Medistim ASA - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Medistim ASA generates 0.98x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Excellent ROA - For every $100 in assets, Medistim ASA generates $ 18.06 in net profit.
Medistim ASA - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.14 | 4.42 | 4.71 |
| Quick Ratio | 1.73 | 2.40 | 2.88 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Nkr264.33 Million | Nkr 279.05 Million | Nkr 229.56 Million |
Medistim ASA - Advanced Valuation Insights
This section examines the relationship between Medistim ASA's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.52 |
| Latest Market Cap to Assets Ratio | 0.40 |
| Asset Growth Rate (YoY) | 13.7% |
| Total Assets | Nkr574.97 Million |
| Market Capitalization | $229.18 Million USD |
Valuation Analysis
Below Book Valuation: The market values Medistim ASA's assets below their book value (0.40 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Medistim ASA's assets grew by 13.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Medistim ASA (2004–2024)
The table below shows the annual total assets of Medistim ASA from 2004 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | Nkr574.97 Million | +13.69% |
| 2023-12-31 | Nkr505.72 Million | +4.78% |
| 2022-12-31 | Nkr482.66 Million | +19.69% |
| 2021-12-31 | Nkr403.24 Million | +16.61% |
| 2020-12-31 | Nkr345.82 Million | +2.89% |
| 2019-12-31 | Nkr336.11 Million | +24.67% |
| 2018-12-31 | Nkr269.59 Million | +7.38% |
| 2017-12-31 | Nkr251.06 Million | +15.67% |
| 2016-12-31 | Nkr217.05 Million | -0.63% |
| 2015-12-31 | Nkr218.44 Million | +7.35% |
| 2014-12-31 | Nkr203.49 Million | +20.84% |
| 2013-12-31 | Nkr168.39 Million | +10.88% |
| 2012-12-31 | Nkr151.87 Million | +1.50% |
| 2011-12-31 | Nkr149.63 Million | +2.52% |
| 2010-12-31 | Nkr145.94 Million | +0.22% |
| 2009-12-31 | Nkr145.63 Million | +0.17% |
| 2008-12-31 | Nkr145.38 Million | +12.88% |
| 2007-12-31 | Nkr128.79 Million | +8.09% |
| 2006-12-31 | Nkr119.15 Million | +40.18% |
| 2005-12-31 | Nkr85.00 Million | +14.57% |
| 2004-12-31 | Nkr74.19 Million | -- |